PLOS one publication
Stemina Biomarker Discovery, Inc. today announced the publication of research conducted in collaboration with the MIND Institute at the University of California-Davis to identify biomarkers in the blood of children with autism spectrum disorders (ASD) that can distinguish them from typically developing children. The research is the first of its kind and has the potential to enable earlier diagnosis and treatment of children with ASD from a blood sample.
- A fasting blood draw is required for the NPDX ASD test. Make sure your child has had nothing to eat or drink except… https://t.co/0fjgcL0yUO23 hours ago
- Open peer review, as shown on sites like Publons, has advantages that could improve the research and review process… https://t.co/ksiq0rB6KCyesterday
- RT @AutismParentMag: How Music Can Help Those With ASD Cope With Anxiety https://t.co/TVdCD8HPHw #Autism https://t.co/uTXxoT2owt2 days ago